The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease

Neuroscience

Volumn 72, Issue 4, 1996, Pages 877-879

  Bandmann, O ^a   Davis, M B ^a   Marsden, C D ^a   Wood, N W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

candidate gene; Parkinson's disease; weaver mouse homologue

Indexed keywords

POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 21; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE ISOLATION; HUMAN; HUMAN TISSUE; MOUSE; MUTANT; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029864810     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00091-7     Document Type: Article

References (31)

1. Agid Y., Javoy-Agid F., Ruberg M. and Hirsch E. (1989) Dopaminergic systems in Parkinson's disease. In Disorders of Movement (eds Quinn N. and Jenner P.), pp. 85-113. Academic Press, London.
2. Duvoisin R. C. and Golbe L. I. (1995) Kindreds of dominantly inherited Parkinson's disease: keys to the riddle. Ann. Neurol. 38, 355-356.
3. Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283-2301.
4. + channel subunits which interact to form G-protein-activated channels. J. biol. Chem. 270, 26,086-26,091.
5. 28K and of the dopaminergic mesocortical projections in weaver mutant mice. Neuroscience 61, 293-305.
6. Gibb W. R. G. (1989) The pathology of parkinsonian disorders. In Disorders of Movement (eds Quinn N. P. and Jenner P. G.), pp. 33-57. Academic Press, London.
7. Goldowitz D. and Smeyne R. J. (1995) Tune into the weaver channel. Nature Genet. 11, 107-109.
8. Gupta M., Felten D. L. and Ghetti B. (1987) Selective loss of monoaminergic neurons in weaver mutant mice-an immunocytochemical study. Brain Res. 402, 379-382.
9. Hornykiewicz O. (1982) Brain neurotransmitter changes in Parkinson's disease. In Movement Disorders (eds Marsden C. D. and Fahn S.), pp. 41-58. Butterworth, London.
10. Hughes A. J., Daniel S. E., Kilford L. and Lees A. J. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease - a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiat. 55, 181-184.
11. Hughes A. J., Daniel S. E., Blankson S. and Lees A. J. (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50, 140-148.
12. Iacobino A. M. and Christakos S. (1990) Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. natn. Acad. Sci. U.S.A. 87, 4078-4082.
13. Iacobino A., Christiakos S., German D., Sonsalla P. K., and Altar C. A. (1992) Calbindin-D28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Molec. Brain. Res. 13, 251-261.
14. Ishikawa K., Mizusawa H., Fujita T., Ohkoshi N., Doi M., Komatsuzaki Y., Iwamoto H., Ogata T., Shoji Sh. (1995) Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J. Neurol. Sci. 129, 179-185.
15. Jenner P. (1994) Oxidative damage in neurodegenerative disease. Lancet 344, 796-798.
16. Johnson W. G., Hodge S. E. and Duvoisin R. (1990) Twin studies and the genetics of Parkinson's disease - a reappraisal. Mov. Disord. 5, 187-194.
17. Lane J. D., Nadi N. S., McBride W. J., Apriso M. H. and Kusano K. (1977) Contents of serotonin, norepinephrine and dopamine in the cerebrum of the 'staggerer', 'weaver' and 'nervous' neurologically mutant mice. J. Neurochem. 29, 349-350.
18. Lazzarini A. M., Myers R. H., Zimmerman T. R., Mark M. H., Golbe L. I., Sage J. I., Johnson W. G. and Duvoisin R. C. (1994) A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 44, 499-506.
19. Lipton S. L. and Rosenberg P. A. (1991) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613-622.
20. Marsden C. D. (1994) Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 57, 672-681.
21. Maraganore D. M., Harding A. E. and Marsden C. D. (1991) A clinical and genetic study of familial Parkinson's disease. Mov. Disord. 6, 205-211.
22. 28k in cultured hippocampal neurons. Neuron 6, 41-51.
23. Okamura H., Yokoyama Ch. and Ibata Y. (1995) Lateromedial gradient of the susceptibility of midbrain dopaminergic neurons to neonatal 6-hydroxydopamine toxicity. Expl Neurol. 136, 136-142.
24. Patil N., Cox D. R., Bhat D., Faham M., Myers R. M. and Peterson A. S. (1995) A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nature Genet. 11, 126-129.
25. Schapira A. H. V. (1994) Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Mov. Disord. 9, 125-138.
26. Schmidt M. J., Sawyer B. D., Perry K. W., Fuller R. W., Foreman M. M. and Ghetti B. (1982) Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2, 376-380.
27. Sidman R. L. (1968) Development of interneuronal connections in brains of mutant mice. In Physiological and Biochemical Aspects of Nervous Integration (ed. Carlson F. D.), pp. 163-193. Prentice-Hall, Englewood Cliffs, NJ.
28. Triarhou L. C., Norton J. and Ghetti B. (1988) Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Expl Brain Res. 70, 256-265.
29. Tsaur M.-L., Menzel S., Lai F. P., Espinosa R. III, Concannon P., Spielman R. S., Hanis C. L., Cox N. J., Le Beau M. M., German M. S., Jan L. Y., Bell G. I. and Stoffel M. (1995) Isolation of a cDNA clone encoding a KATP channel-like protein expressed in insulin-secreting cells, localization of the human gene to chromosome band 21q22.1, and linkage studies with NIIDM. Diabetes 44, 592-596.
30. Verney C., Febvret-Muzerelle A. and Caspar P. (1995) Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Devl Brain Res. 89, 115-119.
31. 28k. Brain Res. 526, 303-307.